Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Julien Cren"'
Autor:
Bruno Pradines, Thierry Fusai, Julien Cren, Philippe Cheval, Rémy Amalvict, Jean Pierre Gardair, P. Hovette, Christophe Rogier, Alain Callec, Joel Mosnier, Eric Baret, Henri Léonard Atanda
Publikováno v:
Journal of Clinical Microbiology. 44:2404-2408
We determined the level of in vitro resistance of Plasmodium falciparum parasites to standard antimalarial drugs, such as chloroquine, quinine, amodiaquine, halofantrine, mefloquine, cycloguanil, and pyrimethamine, and to new compounds, such as dihyd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb6716d3bea2147fd5829b7ae66cf7f
https://doi.org/10.1128/jcm.00623-06
https://doi.org/10.1128/jcm.00623-06
Autor:
Julien Cren, Marilyn Madamet, Bruno Pradines, Daniel Parzy, Dominique Travers, Nicolas Benoit, Nicolas Taudon, Lionel Bertaux, Rémy Amalvict, Christophe Rogier, Aurélie Pascual
Publikováno v:
Malaria Journal
Malaria Journal, 2013, 12 (1), pp.431. ⟨10.1186/1475-2875-12-431⟩
Malaria Journal, BioMed Central, 2013, 12 (1), pp.431. ⟨10.1186/1475-2875-12-431⟩
Malaria Journal, 2013, 12 (1), pp.431. ⟨10.1186/1475-2875-12-431⟩
Malaria Journal, BioMed Central, 2013, 12 (1), pp.431. ⟨10.1186/1475-2875-12-431⟩
Background Dihydroartemisinin-piperaquine is a new ACT that is administered as single daily dose for three days and has been demonstrated to be tolerated and highly effective for the treatment of uncomplicated Plasmodium falciparum malaria. Piperaqui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32f48d03c56b837a00c8392f94b97857
https://pubmed.ncbi.nlm.nih.gov/24274185
https://pubmed.ncbi.nlm.nih.gov/24274185